Analyst: Buy CRH Medical After An "Overdone" Selloff

CRH Medical Corp (NYSE: CRHM)'s 27 percent plunge on Friday in reaction to rate changes by the Medicare & Medicaid Services (CMS) is overdone and investors should consider buying shares on the weak.....»»

Category: blogSource: benzingaJul 17th, 2017

After Beating Cancer, Bernstein Analyst Goes Full "Jerry McGuire"

After taking six months medical leave to deal his lymphoma, Inigo Fraser-Jenkins, the head of global quantitative strategy and European equity strategy at Bernstein Researc.....»»

Category: blogSource: zerohedgeJan 11th, 2018

JPMorgan Diagnoses The MedTech Space: Stock Picks And Pans

The medical technology space for the most part benefited throughout 2017 and heading into 2018 some Wall Street analysts remain bullish. The Analyst JPMorgan's Michael Weinstein. read more.....»»

Category: blogSource: benzingaJan 2nd, 2018

Analyst Sees 3 Red-Hot Medical Technology Stocks as Huge 2018 Buys

These three red-hot companies continue to dominate their specific spheres of the medical technology world, and their stocks have had outstanding runs......»»

Category: blogSource: 247wallstDec 18th, 2017

Abbott Laboratories Makes BMO Capital"s Top Picks List

Abbott Laboratories (NYSE: ABT) had a busy 2017 after acquiring Alere and St. Jude Medical, earning the stock a nod of approval from a Wall Street analyst. .....»»

Category: blogSource: benzingaDec 12th, 2017

Spark Therapeutics Selloff Looks Overdone

A 37% selloff on disappointing gene-therapy test results ignores other promising products in the biotech’s pipeline......»»

Category: topSource: barronsDec 12th, 2017

Analyst: Weakness In Spark Therapeutics Is Overdone

Spark Therapeutics Inc (NASDAQ: ONCE) reported during the ASH conference an update concerning its SPK-8011 therapy, which has many investors concerned. Latest R.....»»

Category: blogSource: benzingaDec 11th, 2017

Cowen: Hologic Is A Relatively Cheap Stock Overdue For Upside

Valuation of Hologic, Inc. (NASDAQ: HOLX) — which manufactures diagnostic products, medical imaging systems and surgical products — is attractive, according to a Cowen analyst.  La.....»»

Category: blogSource: benzingaDec 11th, 2017

CBS: Expect a Comeback Worthy of John Elway?

Shares of CBS have been hit by concerns about slumping NFL viewership but one analyst calls the selloff a buying opportunity......»»

Category: blogSource: barronsDec 6th, 2017

Analyst says bitcoin can't save Square's 'overdone' rally, shares fall 11% after downgrade - CNBC

CNBCAnalyst says bitcoin can't save Square's 'overdone' rally, shares fall 11% after downgradeCNBCOne Wall Street analyst downgrades Square, citing an "overdone" rally and wo.....»»

Category: topSource: googlenewsNov 27th, 2017

Analyst says bitcoin can't save Square's 'overdone' rally, shares fall 6% after downgrade - CNBC

CNBCAnalyst says bitcoin can't save Square's 'overdone' rally, shares fall 6% after downgradeCNBCOne Wall Street analyst downgrades Square, citing an "overdone" rally and w.....»»

Category: topSource: googlenewsNov 27th, 2017

Barron"s: This green-energy stock is getting whacked by tax-reform fears — here’s how to play it

The U.S. market, a trophy for Vestas Wind Systems, is at risk of turning into a turkey, depending on how Washington’s tax-reform push pans out. While bulls say the selloff appears overdone, those taking a cautious stance have a compelling story......»»

Category: topSource: marketwatchNov 20th, 2017

CVS-Aetna deal won’t necessarily make drugs cheaper — and could even raise prices

Savings on medical and pharmacy costs are a major aspect of the deal, but this Wall Street analyst doesn’t see it happening......»»

Category: topSource: marketwatchOct 30th, 2017

Upside And Downside Scenarios For Celgene; Is The Selloff Overdone?


Category: blogSource: benzingaOct 26th, 2017

Enough"s Enough: This Analyst Believes The GoPro Sell-Off Is Overdone

It’s been a long time since Go.....»»

Category: blogSource: benzingaOct 18th, 2017

Weakness In Corcept Shares Is "Overdone," According To Analyst

Corcept Therapeurtics Incorporated (NASDAQ: CORT) shares are down more than 7 percent Tuesday after the company seemingly reported a steep decline in Korlym prescriptions. Latest Ratings for CORT .....»»

Category: blogSource: benzingaOct 10th, 2017

Bond Report: Treasurys retrace losses as investors say September selloff overdone

Treasury prices fell, lifting yields, on early Tuesday after investors turned their attention again back to Trump’s tax reform which could add pressure for the Federal Reserve to raise rates......»»

Category: topSource: marketwatchOct 3rd, 2017

Biogen: Shares Hit By Similar Fears Hitting Sarepta; Analyst Calls Pullback “Inappropriate”

An analyst for Mizuho Securities defended Biogen, saying the earlier weakness in the drug maker's stock price tied to concerns about data on a FDA web site regarding one of its drugs was "overdone and inappropriate.".....»»

Category: blogSource: barronsSep 29th, 2017

NewsWatch: Here’s why value stocks are starting to outperform growth

The big tech selloff that hit the stock market Monday looked like a garden variety case of investors cashing out winners and looking for bargains, but the move actually has less to do with lofty valuations for growth stocks, one analyst says......»»

Category: topSource: marketwatchSep 26th, 2017

Intercept Pharmaceuticals: A Road to Recovery?

A Credit Suisse analyst says the sell off over safety concerns for its liver drug has been overdone......»»

Category: blogSource: barronsSep 25th, 2017

Valeant: No Fundamental Reasons for Today’s Selloff?

One analyst contends there is no fundamental reason for today's decline in Valeant's stock......»»

Category: blogSource: barronsAug 29th, 2017